04E-0402
APP 1
Volume 1

Application

Attachment A - Amino Acid Sequences of the Variable Domains of Bevacizumab

Attachment B - Presta et al., Cancer Res (1997)

Attachment C - AVASTIN Product Label

Attachment D - AVASTIN Approval Letter

Attachment E - FDA Communication Concerning Effective Date of BB-IND # 7023

Attachment F - U.S. Patent No. 6,054,297

Attachment G - Statement Showing Payment of First Maintenance Fee in Patent No. 6,054,297

Attachment H - Power of Attorney